View in EDS

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

Saved in:

Bibliographic Details
Title:	PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Authors:	Guerin, Mathilde¹, Rezai, Keyvan², Isambert, Nicolas³, Campone, Mario⁴, Autret, Aurélie⁵, Pakradouni, Jihane⁵, Provansal, Magali¹, Camerlo, Jacques¹, Sabatier, Renaud¹, Bertucci, François¹, Charafe-Jauffret, Emmanuelle⁶, Hervieu, Alice³, Extra, Jean-Marc¹, Viens, Patrice¹, Lokiec, François², Boher, Jean-Marie^5,7, Gonçalves, Anthony¹ goncalvesa@ipc.unicancer.fr
Source:	European Journal of Cancer. Nov2017, Vol. 86, p28-36. 9p.
Database:	Academic Search Ultimate

Be the first to leave a comment!